Kidney cancer is a type of cancer which starts in kidney cells. Two major types of kidney cancer include transitional cell carcinoma (TCC) and renal cell carcinoma (RCC). Different types of kidney cancer get developed in different ways which imply different long-term outcomes.

The global Kidney Cancer Diagnostics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Kidney Cancer Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Kidney Cancer Diagnostics.

Report Scope

The Kidney Cancer Diagnostics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Kidney Cancer Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Kidney Cancer Diagnostics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Kidney Cancer Diagnostics Market Report

Report Metric	Details
Report Name	Kidney Cancer Diagnostics Market
CAGR	5%
Segment by Type	Immunohistochemistry Urine Analysis Blood Chemistry Test Others
Segment by Application	Hospitals Specialty Clinics Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Kidney Cancer Diagnostics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Kidney Cancer Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Kidney Cancer Diagnostics Market report?

Ans: The main players in the Kidney Cancer Diagnostics Market are Thermo Fisher Scientific, Abbott Laboratories, Illumina, Quest Diagnostics Incorporated, Roche Holding, Myriad Genetics, NeoGenomics Laboratories, NanoString Technologies, Sysmex Corporation, Rosetta Genomics

What are the Application segmentation covered in the Kidney Cancer Diagnostics Market report?

Ans: The Applications covered in the Kidney Cancer Diagnostics Market report are Hospitals, Specialty Clinics, Others

What are the Type segmentation covered in the Kidney Cancer Diagnostics Market report?

Ans: The Types covered in the Kidney Cancer Diagnostics Market report are Immunohistochemistry, Urine Analysis, Blood Chemistry Test, Others

1 Kidney Cancer Diagnostics Market Overview

1.1 Product Overview and Scope of Kidney Cancer Diagnostics

1.2 Kidney Cancer Diagnostics Segment by Type

1.2.1 Global Kidney Cancer Diagnostics Market Value Comparison by Type (2024-2030)

1.2.2 Immunohistochemistry

1.2.3 Urine Analysis

1.2.4 Blood Chemistry Test

1.2.5 Others

1.3 Kidney Cancer Diagnostics Segment by Application

1.3.1 Global Kidney Cancer Diagnostics Market Value by Application: (2024-2030)

1.3.2 Hospitals

1.3.3 Specialty Clinics

1.3.4 Others

1.4 Global Kidney Cancer Diagnostics Market Size Estimates and Forecasts

1.4.1 Global Kidney Cancer Diagnostics Revenue 2019-2030

1.4.2 Global Kidney Cancer Diagnostics Sales 2019-2030

1.4.3 Global Kidney Cancer Diagnostics Market Average Price (2019-2030)

1.5 Assumptions and Limitations

2 Kidney Cancer Diagnostics Market Competition by Manufacturers

2.1 Global Kidney Cancer Diagnostics Sales Market Share by Manufacturers (2019-2024)

2.2 Global Kidney Cancer Diagnostics Revenue Market Share by Manufacturers (2019-2024)

2.3 Global Kidney Cancer Diagnostics Average Price by Manufacturers (2019-2024)

2.4 Global Kidney Cancer Diagnostics Industry Ranking 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Kidney Cancer Diagnostics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Kidney Cancer Diagnostics, Product Type & Application

2.7 Kidney Cancer Diagnostics Market Competitive Situation and Trends

2.7.1 Kidney Cancer Diagnostics Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Kidney Cancer Diagnostics Players Market Share by Revenue

2.7.3 Global Kidney Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Kidney Cancer Diagnostics Retrospective Market Scenario by Region

3.1 Global Kidney Cancer Diagnostics Market Size by Region: 2019 Versus 2023 Versus 2030

3.2 Global Kidney Cancer Diagnostics Global Kidney Cancer Diagnostics Sales by Region: 2019-2030

3.2.1 Global Kidney Cancer Diagnostics Sales by Region: 2019-2024

3.2.2 Global Kidney Cancer Diagnostics Sales by Region: 2025-2030

3.3 Global Kidney Cancer Diagnostics Global Kidney Cancer Diagnostics Revenue by Region: 2019-2030

3.3.1 Global Kidney Cancer Diagnostics Revenue by Region: 2019-2024

3.3.2 Global Kidney Cancer Diagnostics Revenue by Region: 2025-2030

3.4 North America Kidney Cancer Diagnostics Market Facts & Figures by Country

3.4.1 North America Kidney Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.4.2 North America Kidney Cancer Diagnostics Sales by Country (2019-2030)

3.4.3 North America Kidney Cancer Diagnostics Revenue by Country (2019-2030)

3.4.4 United States

3.4.5 Canada

3.5 Europe Kidney Cancer Diagnostics Market Facts & Figures by Country

3.5.1 Europe Kidney Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.5.2 Europe Kidney Cancer Diagnostics Sales by Country (2019-2030)

3.5.3 Europe Kidney Cancer Diagnostics Revenue by Country (2019-2030)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Kidney Cancer Diagnostics Market Facts & Figures by Country

3.6.1 Asia Pacific Kidney Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.6.2 Asia Pacific Kidney Cancer Diagnostics Sales by Country (2019-2030)

3.6.3 Asia Pacific Kidney Cancer Diagnostics Revenue by Country (2019-2030)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Kidney Cancer Diagnostics Market Facts & Figures by Country

3.7.1 Latin America Kidney Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.7.2 Latin America Kidney Cancer Diagnostics Sales by Country (2019-2030)

3.7.3 Latin America Kidney Cancer Diagnostics Revenue by Country (2019-2030)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Kidney Cancer Diagnostics Market Facts & Figures by Country

3.8.1 Middle East and Africa Kidney Cancer Diagnostics Market Size by Country: 2019 VS 2023 VS 2030

3.8.2 Middle East and Africa Kidney Cancer Diagnostics Sales by Country (2019-2030)

3.8.3 Middle East and Africa Kidney Cancer Diagnostics Revenue by Country (2019-2030)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Kidney Cancer Diagnostics Sales by Type (2019-2030)

4.1.1 Global Kidney Cancer Diagnostics Sales by Type (2019-2024)

4.1.2 Global Kidney Cancer Diagnostics Sales by Type (2025-2030)

4.1.3 Global Kidney Cancer Diagnostics Sales Market Share by Type (2019-2030)

4.2 Global Kidney Cancer Diagnostics Revenue by Type (2019-2030)

4.2.1 Global Kidney Cancer Diagnostics Revenue by Type (2019-2024)

4.2.2 Global Kidney Cancer Diagnostics Revenue by Type (2025-2030)

4.2.3 Global Kidney Cancer Diagnostics Revenue Market Share by Type (2019-2030)

4.3 Global Kidney Cancer Diagnostics Price by Type (2019-2030)

5 Segment by Application

5.1 Global Kidney Cancer Diagnostics Sales by Application (2019-2030)

5.1.1 Global Kidney Cancer Diagnostics Sales by Application (2019-2024)

5.1.2 Global Kidney Cancer Diagnostics Sales by Application (2025-2030)

5.1.3 Global Kidney Cancer Diagnostics Sales Market Share by Application (2019-2030)

5.2 Global Kidney Cancer Diagnostics Revenue by Application (2019-2030)

5.2.1 Global Kidney Cancer Diagnostics Revenue by Application (2019-2024)

5.2.2 Global Kidney Cancer Diagnostics Revenue by Application (2025-2030)

5.2.3 Global Kidney Cancer Diagnostics Revenue Market Share by Application (2019-2030)

5.3 Global Kidney Cancer Diagnostics Price by Application (2019-2030)

6 Key Companies Profiled

6.1 Thermo Fisher Scientific

6.1.1 Thermo Fisher Scientific Corporation Information

6.1.2 Thermo Fisher Scientific Description and Business Overview

6.1.3 Thermo Fisher Scientific Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.1.4 Thermo Fisher Scientific Kidney Cancer Diagnostics Product Portfolio

6.1.5 Thermo Fisher Scientific Recent Developments/Updates

6.2 Abbott Laboratories

6.2.1 Abbott Laboratories Corporation Information

6.2.2 Abbott Laboratories Description and Business Overview

6.2.3 Abbott Laboratories Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.2.4 Abbott Laboratories Kidney Cancer Diagnostics Product Portfolio

6.2.5 Abbott Laboratories Recent Developments/Updates

6.3 Illumina

6.3.1 Illumina Corporation Information

6.3.2 Illumina Description and Business Overview

6.3.3 Illumina Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.3.4 Illumina Kidney Cancer Diagnostics Product Portfolio

6.3.5 Illumina Recent Developments/Updates

6.4 Quest Diagnostics Incorporated

6.4.1 Quest Diagnostics Incorporated Corporation Information

6.4.2 Quest Diagnostics Incorporated Description and Business Overview

6.4.3 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product Portfolio

6.4.5 Quest Diagnostics Incorporated Recent Developments/Updates

6.5 Roche Holding

6.5.1 Roche Holding Corporation Information

6.5.2 Roche Holding Description and Business Overview

6.5.3 Roche Holding Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.5.4 Roche Holding Kidney Cancer Diagnostics Product Portfolio

6.5.5 Roche Holding Recent Developments/Updates

6.6 Myriad Genetics

6.6.1 Myriad Genetics Corporation Information

6.6.2 Myriad Genetics Description and Business Overview

6.6.3 Myriad Genetics Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.6.4 Myriad Genetics Kidney Cancer Diagnostics Product Portfolio

6.6.5 Myriad Genetics Recent Developments/Updates

6.7 NeoGenomics Laboratories

6.6.1 NeoGenomics Laboratories Corporation Information

6.6.2 NeoGenomics Laboratories Description and Business Overview

6.6.3 NeoGenomics Laboratories Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.4.4 NeoGenomics Laboratories Kidney Cancer Diagnostics Product Portfolio

6.7.5 NeoGenomics Laboratories Recent Developments/Updates

6.8 NanoString Technologies

6.8.1 NanoString Technologies Corporation Information

6.8.2 NanoString Technologies Description and Business Overview

6.8.3 NanoString Technologies Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.8.4 NanoString Technologies Kidney Cancer Diagnostics Product Portfolio

6.8.5 NanoString Technologies Recent Developments/Updates

6.9 Sysmex Corporation

6.9.1 Sysmex Corporation Corporation Information

6.9.2 Sysmex Corporation Description and Business Overview

6.9.3 Sysmex Corporation Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.9.4 Sysmex Corporation Kidney Cancer Diagnostics Product Portfolio

6.9.5 Sysmex Corporation Recent Developments/Updates

6.10 Rosetta Genomics

6.10.1 Rosetta Genomics Corporation Information

6.10.2 Rosetta Genomics Description and Business Overview

6.10.3 Rosetta Genomics Kidney Cancer Diagnostics Sales, Revenue and Gross Margin (2019-2024)

6.10.4 Rosetta Genomics Kidney Cancer Diagnostics Product Portfolio

6.10.5 Rosetta Genomics Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Kidney Cancer Diagnostics Industry Chain Analysis

7.2 Kidney Cancer Diagnostics Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Kidney Cancer Diagnostics Production Mode & Process

7.4 Kidney Cancer Diagnostics Sales and Marketing

7.4.1 Kidney Cancer Diagnostics Sales Channels

7.4.2 Kidney Cancer Diagnostics Distributors

7.5 Kidney Cancer Diagnostics Customers

8 Kidney Cancer Diagnostics Market Dynamics

8.1 Kidney Cancer Diagnostics Industry Trends

8.2 Kidney Cancer Diagnostics Market Drivers

8.3 Kidney Cancer Diagnostics Market Challenges

8.4 Kidney Cancer Diagnostics Market Restraints

9 Research Finding and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Abbott Laboratories

Illumina Inc

Quest Diagnostics Incorporated

Roche Holding

Myriad Genetics

Neogenomics Laboratories

Nanostring Technologies

Sysmex Corporation

Rosetta Genomics

List of Tables

Table 1. Global Kidney Cancer Diagnostics Market Value Comparison by Type (2024-2030) & (US$ Million)

Table 2. Global Kidney Cancer Diagnostics Market Value Comparison by Application (2024-2030) & (US$ Million)

Table 3. Global Kidney Cancer Diagnostics Market Competitive Situation by Manufacturers in 2023

Table 4. Global Kidney Cancer Diagnostics Sales (K Units) of Key Manufacturers (2019-2024)

Table 5. Global Kidney Cancer Diagnostics Sales Market Share by Manufacturers (2019-2024)

Table 6. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Manufacturers (2019-2024)

Table 7. Global Kidney Cancer Diagnostics Revenue Share by Manufacturers (2019-2024)

Table 8. Global Market Kidney Cancer Diagnostics Average Price (US$/Unit) of Key Manufacturers (2019-2024)

Table 9. Global Key Players of Kidney Cancer Diagnostics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Kidney Cancer Diagnostics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Kidney Cancer Diagnostics, Product Type & Application

Table 12. Global Key Manufacturers of Kidney Cancer Diagnostics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Kidney Cancer Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Kidney Cancer Diagnostics as of 2023)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Kidney Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 17. Global Kidney Cancer Diagnostics Sales by Region (2019-2024) & (K Units)

Table 18. Global Kidney Cancer Diagnostics Sales Market Share by Region (2019-2024)

Table 19. Global Kidney Cancer Diagnostics Sales by Region (2025-2030) & (K Units)

Table 20. Global Kidney Cancer Diagnostics Sales Market Share by Region (2025-2030)

Table 21. Global Kidney Cancer Diagnostics Revenue by Region (2019-2024) & (US$ Million)

Table 22. Global Kidney Cancer Diagnostics Revenue Market Share by Region (2019-2024)

Table 23. Global Kidney Cancer Diagnostics Revenue by Region (2025-2030) & (US$ Million)

Table 24. Global Kidney Cancer Diagnostics Revenue Market Share by Region (2025-2030)

Table 25. North America Kidney Cancer Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 26. North America Kidney Cancer Diagnostics Sales by Country (2019-2024) & (K Units)

Table 27. North America Kidney Cancer Diagnostics Sales by Country (2025-2030) & (K Units)

Table 28. North America Kidney Cancer Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 29. North America Kidney Cancer Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 30. Europe Kidney Cancer Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 31. Europe Kidney Cancer Diagnostics Sales by Country (2019-2024) & (K Units)

Table 32. Europe Kidney Cancer Diagnostics Sales by Country (2025-2030) & (K Units)

Table 33. Europe Kidney Cancer Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 34. Europe Kidney Cancer Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 35. Asia Pacific Kidney Cancer Diagnostics Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 36. Asia Pacific Kidney Cancer Diagnostics Sales by Region (2019-2024) & (K Units)

Table 37. Asia Pacific Kidney Cancer Diagnostics Sales by Region (2025-2030) & (K Units)

Table 38. Asia Pacific Kidney Cancer Diagnostics Revenue by Region (2019-2024) & (US$ Million)

Table 39. Asia Pacific Kidney Cancer Diagnostics Revenue by Region (2025-2030) & (US$ Million)

Table 40. Latin America Kidney Cancer Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Latin America Kidney Cancer Diagnostics Sales by Country (2019-2024) & (K Units)

Table 42. Latin America Kidney Cancer Diagnostics Sales by Country (2025-2030) & (K Units)

Table 43. Latin America Kidney Cancer Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 44. Latin America Kidney Cancer Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Kidney Cancer Diagnostics Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 46. Middle East & Africa Kidney Cancer Diagnostics Sales by Country (2019-2024) & (K Units)

Table 47. Middle East & Africa Kidney Cancer Diagnostics Sales by Country (2025-2030) & (K Units)

Table 48. Middle East & Africa Kidney Cancer Diagnostics Revenue by Country (2019-2024) & (US$ Million)

Table 49. Middle East & Africa Kidney Cancer Diagnostics Revenue by Country (2025-2030) & (US$ Million)

Table 50. Global Kidney Cancer Diagnostics Sales (K Units) by Type (2019-2024)

Table 51. Global Kidney Cancer Diagnostics Sales (K Units) by Type (2025-2030)

Table 52. Global Kidney Cancer Diagnostics Sales Market Share by Type (2019-2024)

Table 53. Global Kidney Cancer Diagnostics Sales Market Share by Type (2025-2030)

Table 54. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Type (2019-2024)

Table 55. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Type (2025-2030)

Table 56. Global Kidney Cancer Diagnostics Revenue Market Share by Type (2019-2024)

Table 57. Global Kidney Cancer Diagnostics Revenue Market Share by Type (2025-2030)

Table 58. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2019-2024)

Table 59. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2025-2030)

Table 60. Global Kidney Cancer Diagnostics Sales (K Units) by Application (2019-2024)

Table 61. Global Kidney Cancer Diagnostics Sales (K Units) by Application (2025-2030)

Table 62. Global Kidney Cancer Diagnostics Sales Market Share by Application (2019-2024)

Table 63. Global Kidney Cancer Diagnostics Sales Market Share by Application (2025-2030)

Table 64. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Application (2019-2024)

Table 65. Global Kidney Cancer Diagnostics Revenue (US$ Million) by Application (2025-2030)

Table 66. Global Kidney Cancer Diagnostics Revenue Market Share by Application (2019-2024)

Table 67. Global Kidney Cancer Diagnostics Revenue Market Share by Application (2025-2030)

Table 68. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2019-2024)

Table 69. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2025-2030)

Table 70. Thermo Fisher Scientific Corporation Information

Table 71. Thermo Fisher Scientific Description and Business Overview

Table 72. Thermo Fisher Scientific Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 73. Thermo Fisher Scientific Kidney Cancer Diagnostics Product

Table 74. Thermo Fisher Scientific Recent Developments/Updates

Table 75. Abbott Laboratories Corporation Information

Table 76. Abbott Laboratories Description and Business Overview

Table 77. Abbott Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 78. Abbott Laboratories Kidney Cancer Diagnostics Product

Table 79. Abbott Laboratories Recent Developments/Updates

Table 80. Illumina Corporation Information

Table 81. Illumina Description and Business Overview

Table 82. Illumina Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 83. Illumina Kidney Cancer Diagnostics Product

Table 84. Illumina Recent Developments/Updates

Table 85. Quest Diagnostics Incorporated Corporation Information

Table 86. Quest Diagnostics Incorporated Description and Business Overview

Table 87. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 88. Quest Diagnostics Incorporated Kidney Cancer Diagnostics Product

Table 89. Quest Diagnostics Incorporated Recent Developments/Updates

Table 90. Roche Holding Corporation Information

Table 91. Roche Holding Description and Business Overview

Table 92. Roche Holding Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 93. Roche Holding Kidney Cancer Diagnostics Product

Table 94. Roche Holding Recent Developments/Updates

Table 95. Myriad Genetics Corporation Information

Table 96. Myriad Genetics Description and Business Overview

Table 97. Myriad Genetics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 98. Myriad Genetics Kidney Cancer Diagnostics Product

Table 99. Myriad Genetics Recent Developments/Updates

Table 100. NeoGenomics Laboratories Corporation Information

Table 101. NeoGenomics Laboratories Description and Business Overview

Table 102. NeoGenomics Laboratories Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 103. NeoGenomics Laboratories Kidney Cancer Diagnostics Product

Table 104. NeoGenomics Laboratories Recent Developments/Updates

Table 105. NanoString Technologies Corporation Information

Table 106. NanoString Technologies Description and Business Overview

Table 107. NanoString Technologies Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 108. NanoString Technologies Kidney Cancer Diagnostics Product

Table 109. NanoString Technologies Recent Developments/Updates

Table 110. Sysmex Corporation Corporation Information

Table 111. Sysmex Corporation Description and Business Overview

Table 112. Sysmex Corporation Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 113. Sysmex Corporation Kidney Cancer Diagnostics Product

Table 114. Sysmex Corporation Recent Developments/Updates

Table 115. Rosetta Genomics Corporation Information

Table 116. Rosetta Genomics Description and Business Overview

Table 117. Rosetta Genomics Kidney Cancer Diagnostics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 118. Rosetta Genomics Kidney Cancer Diagnostics Product

Table 119. Rosetta Genomics Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Kidney Cancer Diagnostics Distributors List

Table 123. Kidney Cancer Diagnostics Customers List

Table 124. Kidney Cancer Diagnostics Market Trends

Table 125. Kidney Cancer Diagnostics Market Drivers

Table 126. Kidney Cancer Diagnostics Market Challenges

Table 127. Kidney Cancer Diagnostics Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

List of Figures

Figure 1. Product Picture of Kidney Cancer Diagnostics

Figure 2. Global Kidney Cancer Diagnostics Market Value Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Kidney Cancer Diagnostics Market Share by Type in 2023 & 2030

Figure 4. Immunohistochemistry Product Picture

Figure 5. Urine Analysis Product Picture

Figure 6. Blood Chemistry Test Product Picture

Figure 7. Others Product Picture

Figure 8. Global Kidney Cancer Diagnostics Market Value Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Kidney Cancer Diagnostics Market Share by Application in 2023 & 2030

Figure 10. Hospitals

Figure 11. Specialty Clinics

Figure 12. Others

Figure 13. Global Kidney Cancer Diagnostics Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global Kidney Cancer Diagnostics Market Size (2019-2030) & (US$ Million)

Figure 15. Global Kidney Cancer Diagnostics Sales (2019-2030) & (K Units)

Figure 16. Global Kidney Cancer Diagnostics Average Price (US$/Unit) & (2019-2030)

Figure 17. Kidney Cancer Diagnostics Report Years Considered

Figure 18. Kidney Cancer Diagnostics Sales Share by Manufacturers in 2023

Figure 19. Global Kidney Cancer Diagnostics Revenue Share by Manufacturers in 2023

Figure 20. The Global 5 and 10 Largest Kidney Cancer Diagnostics Players: Market Share by Revenue in 2023

Figure 21. Kidney Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023

Figure 22. Global Kidney Cancer Diagnostics Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Figure 23. North America Kidney Cancer Diagnostics Sales Market Share by Country (2019-2030)

Figure 24. North America Kidney Cancer Diagnostics Revenue Market Share by Country (2019-2030)

Figure 25. United States Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 26. Canada Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 27. Europe Kidney Cancer Diagnostics Sales Market Share by Country (2019-2030)

Figure 28. Europe Kidney Cancer Diagnostics Revenue Market Share by Country (2019-2030)

Figure 29. Germany Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 30. France Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 31. U.K. Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 32. Italy Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 33. Russia Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Kidney Cancer Diagnostics Sales Market Share by Region (2019-2030)

Figure 35. Asia Pacific Kidney Cancer Diagnostics Revenue Market Share by Region (2019-2030)

Figure 36. China Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 37. Japan Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 38. South Korea Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 39. India Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 40. Australia Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 41. China Taiwan Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 42. Indonesia Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 43. Thailand Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 44. Malaysia Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 45. Latin America Kidney Cancer Diagnostics Sales Market Share by Country (2019-2030)

Figure 46. Latin America Kidney Cancer Diagnostics Revenue Market Share by Country (2019-2030)

Figure 47. Mexico Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 48. Brazil Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 49. Argentina Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 50. Middle East & Africa Kidney Cancer Diagnostics Sales Market Share by Country (2019-2030)

Figure 51. Middle East & Africa Kidney Cancer Diagnostics Revenue Market Share by Country (2019-2030)

Figure 52. Turkey Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 53. Saudi Arabia Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 54. UAE Kidney Cancer Diagnostics Revenue Growth Rate (2019-2030) & (US$ Million)

Figure 55. Global Sales Market Share of Kidney Cancer Diagnostics by Type (2019-2030)

Figure 56. Global Revenue Market Share of Kidney Cancer Diagnostics by Type (2019-2030)

Figure 57. Global Kidney Cancer Diagnostics Price (US$/Unit) by Type (2019-2030)

Figure 58. Global Sales Market Share of Kidney Cancer Diagnostics by Application (2019-2030)

Figure 59. Global Revenue Market Share of Kidney Cancer Diagnostics by Application (2019-2030)

Figure 60. Global Kidney Cancer Diagnostics Price (US$/Unit) by Application (2019-2030)

Figure 61. Kidney Cancer Diagnostics Value Chain

Figure 62. Kidney Cancer Diagnostics Production Process

Figure 63. Channels of Distribution (Direct Vs Distribution)

Figure 64. Distributors Profiles

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-14C14333

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Cancer Diagnostic Test Kits - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-28P13808

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Gamma Knife Radiosurgery (GKRS) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-29R14086

Fri Nov 08 00:00:00 UTC 2024

Add to Cart

Adult Malignant Glioma Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-12R14095

Wed Nov 06 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Kidney Cancer Diagnostics Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-10D8044

Global Kidney Cancer Diagnostics Market Research Report 2024

FEATURED COMPANIES

Kidney Cancer Diagnostics Market Size

Kidney Cancer Diagnostics Market

Report Scope

Scope of Kidney Cancer Diagnostics Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Kidney Cancer Diagnostics Market report?

What are the Application segmentation covered in the Kidney Cancer Diagnostics Market report?

What are the Type segmentation covered in the Kidney Cancer Diagnostics Market report?

FEATURED COMPANIES

RELATED REPORTS